LPL Financial
KRBP

LPL Financial’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

LPL Financial’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,739
Closed -$70K – 4566
2022
Q1 		$70K Sell
2,739
-74
-3% -$2.19K ﹤0.01% 4021
2021
Q4 		$129K Buy
2,813
+1,053
+60% +$71.7K ﹤0.01% 4083
2021
Q3 		$162K Buy
+1,760
New +$182K ﹤0.01% 4045

Other funds holding KRBP

ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's KRBP Position: Q2 2022 in Review

LPL Financial sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q2 2022, closing a stake of 2,739 shares — an estimated $70K sold.

LPL Financial first reported a position in KRBP in Q3 2021 and held it in 3 quarters. The position peaked at $162K in Q3 2021. 17 funds tracked by Wall St. Rank hold KRBP as of Q2 2022.

  • LPL Financial reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • LPL Financial sold 2,739 Kiromic BioPharma, Inc. Common Stock shares in Q2 2022, an estimated $70K.
  • LPL Financial first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • LPL Financial's Kiromic BioPharma, Inc. Common Stock position peaked at $162K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q2 2022.

Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.